TREATMENT WITH ANTI-TUMOR NECROSIS FACTOR (TNF) BIOLOGICS TO HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 (HTLV-1) POSITIVE PATIENTS WITH RHEUMATOID ARTHRITIS (RA) : A CASE-CONTROL STUDY

被引：0
|
作者：
Miyauchi, S. [1 ]
Umekita, K. [1 ]
Hidaka, T. [2 ]
Hashiba, Y. [2 ]
Kawaguchi, T. [1 ]
Matsuda, M. [1 ]
Kubo, K. [1 ]
Ueno, S. [1 ]
Kusumoto, N. [1 ]
Takajo, I. [1 ]
Kai, Y. [2 ]
Nagatomo, Y. [1 ]
Okayama, A. [1 ]
机构：
[1] Miyazaki Univ, Dept Internal Med Rheumatol Infect Dis & Lab Med, Miyazaki, Japan
[2] Zenjinkai Shimin No Mori Hosp, Inst Rheumatol, Miyazaki, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：437 / 438
页数：2
相关论文
共 50 条
  • [1] Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series
    Umekita, Kunihiko
    Umeki, Kazumi
    Miyauchi, Shunichi
    Ueno, Shiro
    Kubo, Kazuyoshi
    Kusumoto, Norio
    Takajo, Ichiro
    Nagatomo, Yasuhiro
    Okayama, Akihiko
    [J]. MODERN RHEUMATOLOGY, 2015, 25 (05) : 794 - 797
  • [2] Human T-lymphotropic virus type 1 (HTLV-1)
    Lefrère, JJ
    [J]. PRESSE MEDICALE, 2000, 29 (20): : 1134 - 1138
  • [3] Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control
    Charles R. M. Bangham
    [J]. International Journal of Hematology, 2003, 78 : 297 - 303
  • [4] Human T-lymphotropic virus type 1 (HTLV-1): Persistence and immune control
    Bangham, CRM
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (04) : 297 - 303
  • [5] Treatment With Anti-Tumor Necrosis Factor Biologic Agents in Human T Lymphotropic Virus Type I-Positive Patients With Rheumatoid Arthritis
    Umekita, Kunihiko
    Hidaka, Toshihiko
    Miyauchi, Shunichi
    Ueno, Shiro
    Kubo, Kazuyoshi
    Takajo, Ichiro
    Hashiba, Yayoi
    Kai, Yasufumi
    Nagatomo, Yasuhiro
    Okayama, Akihiko
    [J]. ARTHRITIS CARE & RESEARCH, 2014, 66 (05) : 788 - 792
  • [6] IL-6 May Have an Important Role in the Resistance to Anti-TNF Therapies of Human T-Lymphotropic Virus Type 1 (HTLV-1) Positive Rheumatoid Arthritis (RA) Patients; HTLV-1 Infected Cells Activate the Inflammatory Responses of RA Synovial Fibroblasts
    Umekita, Kunihiko
    Miyauchi, Shunichi
    Kubo, Kazuyoshi
    Umeki, Kazumi
    Nomura, Hajime
    Komura, Mao
    Iwao, Koushou
    Takajo, Ichiro
    Nagatomo, Yasuhiro
    Hidaka, Toshihiko
    Okayama, Akihiko
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] DETECTION OF ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 (HTLV-1)
    FANG, CT
    WILLIAMS, AE
    SANDLER, SG
    SLAMON, DJ
    POIESZ, BJ
    [J]. TRANSFUSION, 1988, 28 (02) : 179 - 183
  • [8] Prevalence of Human T-lymphotropic Virus Type 1 (HTLV-1) Infection in Patients with Different Etiologies
    Ghaffari, Javad
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (06) : 353 - 353
  • [9] TOCILIZUMAB IS CLINICALLY EFFECTIVE AND SAFE FOR HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 POSITIVE PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE NOT RESPONSIVE TO ANTI-TNF TREATMENT
    Umekita, K.
    Hidaka, T.
    Miyauchi, S.
    Kubo, K.
    Hashiba, Y.
    Okayama, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 932 - 932
  • [10] Human T-lymphotropic virus 1 (HTLV-1) pathogenesis: A systems virology study
    Mozhgani, Sayed-Hamidreza
    Zarei-Ghobadi, Mohadeseh
    Teymoori-Rad, Majid
    Mokhtari-Azad, Talat
    Mirzaie, Mehdi
    Sheikhi, Mohsen
    Jazayeri, Seyed-Mohammad
    Shahbahrami, Ramin
    Ghourchian, Hedayatollah
    Jafari, Mohieddin
    Rezaee, Seyed-Abdolrahim
    Norouzi, Mehdi
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (05) : 3968 - 3979
12345